These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27589337)

  • 21. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway.
    Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y
    Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
    Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
    Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HpSulf, a heparan sulfate 6-O-endosulfatase, is involved in the regulation of VEGF signaling during sea urchin development.
    Fujita K; Takechi E; Sakamoto N; Sumiyoshi N; Izumi S; Miyamoto T; Matsuura S; Tsurugaya T; Akasaka K; Yamamoto T
    Mech Dev; 2010 Apr; 127(3-4):235-45. PubMed ID: 20036737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
    Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
    Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
    Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance.
    Lei Y; Geng Z; Guo-Jun W; He W; Jian-Lin Y
    Mol Cell Biochem; 2010 Nov; 344(1-2):23-31. PubMed ID: 20563741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma.
    Chen F; Bai J; Li W; Mei P; Liu H; Li L; Pan Z; Wu Y; Zheng J
    PLoS One; 2013; 8(2):e56241. PubMed ID: 23457532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.
    Yang JD; Sun Z; Hu C; Lai J; Dove R; Nakamura I; Lee JS; Thorgeirsson SS; Kang KJ; Chu IS; Roberts LR
    Genes Chromosomes Cancer; 2011 Feb; 50(2):122-35. PubMed ID: 21104785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism and function of decreased FOXO1 in renal cell carcinoma.
    Zhou L; Yin B; Liu Y; Hong Y; Zhang C; Fan J
    J Surg Oncol; 2012 Jun; 105(8):841-7. PubMed ID: 22213032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
    Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
    Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
    Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
    Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
    Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced E-cadherin facilitates renal cell carcinoma progression by WNT/β-catenin signaling activation.
    Zhang X; Yang M; Shi H; Hu J; Wang Y; Sun Z; Xu S
    Oncotarget; 2017 Mar; 8(12):19566-19576. PubMed ID: 28223537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells.
    Nawroth R; van Zante A; Cervantes S; McManus M; Hebrok M; Rosen SD
    PLoS One; 2007 Apr; 2(4):e392. PubMed ID: 17460759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
    Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
    Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
    Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.